Clinical Trials Browser

Phase 2 × Melanoma × technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran × Clear all

NCT02509598 2024-06-28

A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping

Phase 2 Completed

24 enrolled 18 charts

DermatologicSarcoma

Melanoma, Rhabdomyosarcoma